tein-coupled receptor KISS1R (also known as GPR54). All kisspeptins show the same affinity of binding to the receptor, indicating that the C-terminal end is responsible for binding and activation [1] [2] [3] [4] .
Kisspeptins are potent stimulators of GnRH-producing neurons and together with their receptor, KISS1r, they are required for normal functioning of the hypothalamic-pituitary-gonadal (HPG) axis. Loss-of-function mutations in the KISS1R and the KISS1 gene, as demonstrated in humans and mice, lead to isolated hypogonadotrophic hypogonadism caused by deficient GnRH secretion and, consequently, deficient pituitary secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). This results in the impairment of both pubertal maturation and reproductive function [3, [5] [6] [7] [8] [9] [10] . The relevance of kisspeptin signalling is further underlined by the identification of activating mutations of the KISS1R and KISS1 genes in children with precocious puberty due to premature activation of GnRH secretion [11, 12] . Central (intracerebroventricular) or peripheral (intravenous, subcutaneous or intraperitoneal) administration of different types of kisspeptin stimulates gonadotrophin secretion in several mammalian species, including humans [13] [14] [15] [16] [17] [18] . Furthermore, intracerebroventricular administration of kisspeptin antagonists prevents the preovulatory LH surge in rats and blocks the post-castration rise in circulating LH in mice, rats and sheep [19, 20] . Additionally, kisspeptins are involved in the feedback regulation of the HPG axis by gonadal steroids [4, 17, [21] [22] [23] . Based on these observations, kisspeptin operates proximally (upstream) to GnRH and the kiss1/kiss1r system is thus regarded as the gatekeeper of reproductive function. Kisspeptin is thus an interesting target for therapeutic interventions in reproduction such as induction of ovulation and puberty. Furthermore, via the inhibition of kisspeptin signalling, non-surgical oestrus prevention may be achieved.
The reproductive cycle of the domestic bitch (Canis lupus familiaris) is complex and differs from that of most other mammalian species. A follicular phase with spontaneous ovulation is followed by a luteal phase lasting about 2 months, almost irrespective of whether the bitch is pregnant, and a non-seasonal anoestrus of 2-10 months [24] .
The role of the kiss1/kiss1r system in the HPG axis in dogs has not been determined. Since the kiss1/kiss1r system is not operative in some species (e.g. chicken and zebra finch) it is important to establish its functionality in dogs. The presence of a functional kiss1/kiss1r system in the dog may lead to new therapeutic opportunities such as non-surgical contraception, oestrus prevention and ovulation induction. The aim of the present study was, therefore, to identify the existence of the canine kiss1 and kiss1r genes and to determine whether the system is operative in the dog. We report here the identification and primary sequence of the canine kiss1 and kiss1r genes and the effects of different dosages of intravenously administered canine KP-10 on the gonadotropic hormones and oestradiol in anoestrous bitches.
Materials and Methods

Identification of Canine kiss1 and kiss1r Genes
The canine kiss1 and kiss1r genes were localized by comparing the reference dog genome build 2.2 with the relevant human cDNA sequences using BLASTn software [25] . The GenBank accession of human cDNA was NM_002256 for KISS1 and NM_032551 for KISS1R . In addition, we analysed the DNA sequence of bacterial artificial chromosome (BAC) clones selected from the chromosomal region of KISS1R using the UCSC genome browser (http:// genome.ucsc.edu). The BAC clones CH82-333G1, CH82-325G21 and CH82-156G16 were obtained from the Children's Hospital Oakland Research Institute (http://bacpac.chori.org/library. php?id = 253) and used to complete the coding DNA sequences of the canine kiss1r gene. BAC DNA was isolated using the HiSpeed ® Plasmid Maxi Kit (Qiagen). A standard PCR using primers 5 ′ -GACCTCAAGCCTCCACTGTC-3 ′ and 5 ′ -CGAGTTGCTG-TAGGACATGC-3 ′ was performed with BAC DNA as a template. These primers bridge a DNA sequence missing from the reference genome build 2.2 and were designed using high-quality trace files of the dog genome project (http://www.ncbi.nlm.nih.gov/Traces/ trace.cgi). These and additional primers 5 ′ -CATCTGGGGAG-TGGGCTCAA-3 ′ and 5 ′ -GAGGAGGGAGGAGGCAAGGT-3 ′ were used in the subsequent tercycle reactions with BigDye v3.1 according to the protocol of the manufacturer (Applied Biosystems). The reaction products were purified by ethanol precipitation in the presence of EDTA and analysed on a 3130xl Genetic Analyzer (Applied Biosystems).
The splice sites of kiss1 were identified by first blocking out repetitive DNA sequences from the chromosome region of the gene using RepeatMasker (http://www.repeatmasker.org), followed by prediction of the splice sites using NNSPLICE 0.9 (http://www. fruitfly.org/seq_tools/splice.html) [26] .
Animals, Experimental Design and Collection of Blood Samples
A total of 6 healthy Beagle bitches, with a median age of 70 months (range 21-111), and a median weight of 12.7 kg (range 11-18.2) were used for the first part of the study (dosages of 1-30 μg/kg of canine KP-10; high-dosage group). Afterwards another group of 6 healthy Beagle bitches, with a median age of 36 months (range , and a median weight of 13.0 kg (range 12-15.8) were used for the second part of this study (dosages of 0-1 μg/kg of canine KP-10; low-dosage group). All were born and raised in the Department of Clinical Sciences of Companion Animals and were accustomed to the laboratory environment and procedures such as the collection of blood. They were housed in pairs in in-180 door/outdoor runs, fed a standard commercial dog food once daily and provided with water ad libitum.
All dogs were examined thrice weekly for swelling of the vulva and serosanguineous vaginal discharge, signifying the onset of pro-oestrus. Plasma progesterone concentration was measured thrice weekly from the start of pro-oestrus until it exceeded 13-16 nmol/l, at which time ovulation is assumed to occur [27] [28] [29] . Anoestrus was defined as the period from 100 days after ovulation to the onset of pro-oestrus, as indicated by vulvar swelling and serosanguineous discharge.
Canine KP-10 was administered as a single bolus via the cephalic vein at weekly intervals during anoestrus. Blood samples were collected from the jugular vein by repeated venipuncture directly into heparinized tubes at 40 and 0 min before and at 10, 20, 30, 40, 60, 90, and 120 min after canine KP-10 administration. In the high-dosage group, LH and FSH concentrations were measured in all plasma samples and the oestradiol concentration in samples collected before and at 20, 60, 90, and 120 min after canine KP-10. To determine whether the plasma gonadotrophin and oestradiol response was influenced by the time in anoestrus and whether there was a cumulative effect of repeated administration of different doses of canine KP-10, 3 bitches received canine KP-10, starting at 30 μg/kg (23.1 nmol/kg) and then decreasing at weekly intervals to 10, 5, 1, and 0 μg/kg (7.7, 3.8, 0.77, and 0 nmol/ kg, respectively), and 3 bitches received canine KP-10 in the reverse order, starting with 0 μg/kg and then increasing to 1, 5, 10, and 30 μg/kg.
Next, lower dosages of canine KP-10 were used to determine the lowest canine KP-10 dose causing a significant LH response. Dosages of 0, 0.2, 0.3, 0.5, and 1 μg/kg (0, 0.15, 0.23, 0.38, and 0.77 nmol/kg, respectively) were administered as a single bolus via the cephalic vein during anoestrus and blood samples for the determination of plasma LH concentrations were collected from the jugular vein by repeated venipuncture directly into heparinized tubes at 40 and 0 min before and at 10, 20, 30, 40, 60, 90, and 120 min after canine KP-10 administration.
Peptides
Canine KP-10 (YNWNVFGLRYNH2) was produced by Eurogentec (Maastricht, the Netherlands) with a purity of 99.5%, dissolved in saline, and divided into individual doses in glass vials which were stored at -20 ° C and then thawed at room temperature on the day of use.
Hormone Measurements
Plasma progesterone concentration was measured thrice weekly during the follicular phase to determine the ovulation period, using a 125 I radioimmunoassay previously validated for ovulation timing [30] . The intra-and interassay coefficients of variation (CVs) were 6 and 10.8%, respectively, and the limit of quantitation was 0.13 nmol/l.
Plasma LH concentration was measured with a heterologous radioimmunoassay, as described previously [31, 32] . The intraand interassay CVs for values above 0.5 μg/l were 2.3 and 10.5%, respectively, and the limit of quantitation was 0.3 μg/l. Plasma FSH was measured by immunoradiometric assay (AHROO4; Biocode SA, Liège, Belgium), according to the manufacturer's instructions and as described previously by Beijerink et al. [33] (2007). The intra-and interassay CVs were 3.0 and 6.0%, respectively. The lower limit of quantitation was 0.5 μg/l. Plasma oestradiol-17β was measured by radioimmunoassay (Siemens Medical Solution Diagnostics, Los Angeles, Calif., USA) according to the manufacturer's instructions with modifications as described previously [34] and validated for the dog [35] . The intraand interassay CVs were 14 and 11.8%, respectively. The lower limit of quantitation was 7 pmol/l.
Data Analysis
Basal plasma LH, FSH and oestradiol concentrations were calculated for each dog as the mean of the values at -40 and 0 min before canine KP-10 administration. The mean of all plasma LH concentrations measured before the administration of canine KP-10 was also calculated. All LH values before KP-10 administration that exceeded this overall mean plus 3 SD were ascribed to pulsatile secretion and were treated as outliers and excluded from statistical analysis.
The area under the curve (AUC) for LH, FSH and oestradiol was calculated from 0 to 120 min after the administration of canine KP-10. Differences in AUCs between different dosages of canine KP-10 were analysed by a two-way ANOVA followed by a post hoc Student-Newman-Keuls test.
Plasma LH, FSH and oestradiol responses to different doses of canine KP-10 were analysed by nonparametric tests because not all data were normally distributed. A Friedman test followed by a post hoc Dunnett test was used to determine differences in plasma LH, FSH and oestradiol concentration before and after canine KP-10 administration.
The influence of the order of administered doses of canine KP-10 was analysed by a Mann-Whitney U test. p < 0.05 was considered significant.
Ethics of Experimentation
This study was approved by the Ethics Committee of the Faculty of Veterinary Medicine of Utrecht University.
Results
In silico Identification of the Canine kiss1 and kiss1r Genes
The chromosomal location of the canine kiss1 gene was identified by a similarity search of the dog genome with the human cDNA sequence. Two closely situated fragments on chromosome 38 of the dog are highly similar to parts of human cDNA. The region containing these fragments is flanked by orthologs of REN and GOLT1A , which also flank human KISS1 , confirming the identity of the canine gene. The alignment of human cDNA with the region on CFA38 was incomplete because of a lack of similarity between parts of the DNA sequences. The two highly similar fragments are respective parts of the two coding exons of the gene. The first part contains the putative start codon of the gene and the second part the putative KP-10 coding sequence. The putatively complete kiss1 coding sequence was identified by prediction of the intron between the two coding exons and by localization of the first stop codon in frame with the KP-10 coding sequence. The splice donor site was predicted at nucleotide position 103 from the translation start codon and the predicted length of the intron was 1,738 nucleotides.
The predicted mRNA of prepro-kisspeptin encodes a peptide of 111 amino acids ( fig. 1 ). The amino acid sequence of canine KP-10 differs from that of human KP-10 at positions 5 and 10. The amino acid sequence is YNWNVFGLRY in canine KP-10 and YNWNSFGLRF in human KP-10.
A portion of the canine kiss1r cDNA sequence had already been predicted from the reference genome build 2.2 (GenBank accession XM_850105.1). Because of a gap in the reference genome sequence that overlapped with exon 4 and intron 4, it was not possible to predict the correct mRNA sequence. By DNA sequence analysis of BAC clones from the region, exon 4 could be completed and it fully aligned with the corresponding part of the human cDNA sequence of KISS1R . The DNA sequence traces obtained with one of the primers showed a sudden loss of signal, indicating the presence of DNA elements that hamper the processivity of the DNA polymerase of the BigDye terminator kit (data not shown). Hence we were not able to complete the DNA sequence of intron 4. The unconserved 3 ′ -part of the gene was based on the GNOMON prediction of GenBank. The predicted mRNA for canine KISS1R encodes a protein of 397 amino acid residues ( fig. 2 ). The identity of amino acid sequences between the canine and the human KISS1R is 75% and it increases to 90% when the unconserved C-terminal domain is ignored. 
Stimulation Tests with Canine KP-10 in the High-Dosage Group
The control saline administered at T = 0 did not alter plasma LH, FSH and oestradiol concentrations, whereas all dosages of canine KP-10 in the high-dosage group resulted in significant increases in all three hormones measured ( fig. 3 ; table 1 ). There was no difference in the LH, FSH and oestradiol responses between the dogs in which the weekly dosage of canine KP-10 increased and those in which it decreased.
Peak plasma LH concentrations occurred at 10 min after canine KP-10 administration at all doses. The mean maximal LH responses were 13-fold over basal plasma LH concentrations for 1 μg/kg, 12-fold for 5 μg/kg, 14-fold for 10 μg/kg, and 10-fold for 30 μg/kg. Plasma LH concentrations had returned to basal levels at 40 min after every dose of canine KP-10.
The maximal FSH response was usually observed at 10 min after canine KP-10 administration but in dogs 1-3 it was at 20 min with every dosage. The mean maximal FSH responses were 3-fold over basal plasma FSH concentrations for all dosages. Plasma FSH concentrations had returned to basal levels at 60 min after 1 μg/kg of canine KP-10 and at 40 min after 5, 10 and 30 μg/kg.
Maximal plasma oestradiol concentrations were reached at 60 min after the administration of 5 and 10 μg/ kg of canine KP-10 and at 90 min after 1 μg/kg. After the administration of 30 μg/kg of canine KP-10 there was no significant increase in plasma oestradiol concentration; 1 dog showed no evident oestradiol response, but in the other 5 dogs the response was similar to that with other dosages. The mean maximal oestradiol responses were 2-fold over basal concentrations for dosages of 1 and 10 μg/kg and 3-fold for 5 μg/kg. Plasma oestradiol concen- trations returned to basal levels at 120 min after 1 μg/kg of canine KP-10 but still differed from basal levels after 5 and 10 μg/kg of canine KP-10 administration. The AUCs of plasma LH and FSH concentrations were significantly higher than controls after canine KP-10 administration at all doses, but the differences in AUCs between dosages were not significant. The AUCs of plasma oestradiol concentrations after canine KP-10 administration were significantly higher than controls at 1, 5 and 10 μg/kg ( fig. 4 ). There were no significant differences in AUCs of oestradiol between the dosages.
Stimulation Tests with Canine KP-10 in the Low-Dosage Group
Both the control saline and 0.1 μg/kg of canine KP-10 did not result in a significant increase of plasma LH concentrations. In contrast, plasma LH concentrations significantly increased after the administration of 0.2, 0.3, 0.5, and 1 μg/kg of canine KP-10 ( fig. 5 ; table 2 ). Plasma LH concentrations reached a maximum at T = 10 at all of these dosages and returned to basal levels at 30 min after 0.2 and 0.3 μg/kg of canine KP-10 and at 40 min after 0.5 and 1 μg/kg. Mean maximum LH responses were 3-, 4-, 5-, and 6-fold over basal concentrations after 0.2, 0.3, 0.5, and 1 μg/kg of canine KP-10, respectively. The AUC of plasma LH concentration of the controls did not differ significantly from that after the administration of 0.1 μg/kg of canine KP-10 ( fig. 6 ). AUCs of plasma LH concentration with 0.2, 0.3, 0.5, and 1 μg/kg were significantly higher than those of the control group. There was no difference in AUCs between 0.2, 0.3, 0.5, and 1 μg/kg
Discussion
Canine kiss1 and kiss1r Genes
This study shows that coding sequences of both kiss1 and kiss1r are conserved in the canine genome. In humans the KISS1 gene encodes a prepro-protein of 138 amino acids. The predicted canine prepro-kisspeptin consists of 111 amino acids. The size difference is due to the divergence of the central part of the protein in the evolution of canids. This central part is not well conserved in mammals and its size in some species other than the dog also differs considerably from that in humans. The putative N-terminal signal sequence has identical residues at 15 of the 19 positions of the KISS1 prepro-protein in the human and the dog. This level of similarity is higher than between the human and the mouse, which have 11 of the 19 N-terminal residues in common. The dog prepro-protein has a potential dibasic cleavage site at position 65 and a RYGR cleavage/amidation site at position 80. The use of these sites would yield a kisspeptin of only 16 residues compared with KP-54 in hu- mans. The amidated C-terminal stretch of 10 amino acid residues of the bioactive kisspeptin peptides is responsible for the binding and activation of the receptor [36] . It is interesting to note that human and canine KP-10 differ in 2 amino acids. There is more similarity with other mammalian species such as rats, mice, sheep, and cattle. All of these species have kisspeptins with an RY sequence at the C-terminus, while humans have an RF sequence. The conservative substitution of F-and Y-terminal residues between species is common for peptides that are cleaved and amidated at this position [1] [2] [3] [4] It indicates that the hydroxyl moiety is not required for receptor binding and activation. This is supported by structure/ activity studies which show that any aromatic residue at this site is tolerable for binding and activation of the receptor [36] . The second structural difference is, however, intriguing. The substitution of Ser with Val is unexpected, because structure/activity studies indicate that a hydroxyl side chain is required such that the conservative substitution of Thr is tolerated. This may suggest that the dog receptor differs in its requirements for the amino acid in this position and interacts with a methyl side chain rather than a hydroxyl, as occurs in Val. Cloning and mutational in vitro studies comparing the canine receptor with the human receptor will clarify this issue. Such studies will also indicate whether the canine KP-10 might be the starting point for the development of a new series of agonists.
The similarity between the human kisspeptin receptor and the predicted canine kisspeptin receptor is striking. Overall, there is about 75% similarity, with the largest differences at the (unconserved) C-terminus. The central 333 residues of the human and canine proteins have a similarity of 91%. This is also the case for other mammals such as mice, rats and cattle [37] . The canine kisspeptin receptor retains the classical hallmarks of rhodopsin family G-protein-coupled receptors such as the conserved prolines in transmembrane domains TM1, TM3-TM7, asparagine in TM1, and aspartate in TM2 interacting with asparagine in TM7. It also has the DRY/W motif on the intracellular end of TM3 and the NPXXY motif in TM7, which are involved in receptor activation. The similarities in both kisspeptin and its receptor suggest that the role of the kisspeptin system in the dog is similar to that in other species.
Canine KP-10 Stimulation of LH, FSH and Oestradiol
Canine KP-10 robustly and rapidly stimulated LH secretion at all dosages except 0.1 μg/kg. The plasma LH concentration reached a peak at 10 min, which is much earlier than in humans, calves, goats, and rats (about 30 min) [16, [38] [39] [40] [41] . Since the half-life of LH is similar among mammalian species, this suggests that canine KP-10 has a more rapid receptor on-rate [31] . The maximum plasma LH concentration at 10 min after canine KP-10 administration in the high-dosage group represented a mean maximum of >10-fold increase above the basal plasma LH concentration -substantially more than that reported in other mammals and more rapidly reached (10 vs. 20 min). The mean maximum rise in plasma LH concentration after intravenous KP-10 administration was about 3-fold in men and women, 6-fold in goats and sheep and 7-fold in prepubertal calves [16, [38] [39] [40] 42] . The greater response of LH in anoestrous bitches is unlikely to be due to physiological/sex steroid status as the above studies represent a spectrum of anoestrous, castrate, post-menopausal, steroid treated, and amenorrhoeic conditions. It, therefore, appears likely that either the canine GnRH neuron is particularly responsive to kisspeptin or the canine gonadotroph is more sensitive to GnRH. It is possible that canine KP-10 is more efficacious in its coupling to the canine kiss1r. Resolution of this question will require in vitro studies of the responses of cloned canine kiss1r. We are currently unable to address this question as we have yet to clone the canine receptor.
The maximum plasma LH concentration in both the low-and the high-dosage group rapidly reached 10 min after canine KP-10 administration. There was, however, a difference between the fold change from basal to maximum LH response after the administration of 1 μg/kg in both groups (13-fold in the high-dosage group and 6-fold in the low-dosage group). The difference in fold change may be related to the fact that the basal plasma LH concentrations in the low-dosage group were twice as high as in the high-dosage group. Because the maximum LH responses were similar in both groups, this resulted in a difference in fold changes. Furthermore, the fold changes in LH after the administration of GnRH differ considerably in dogs. The rise in plasma LH concentration compared to basal values after intravenous administration of the GnRH analogue gonadorelin to anoestrous bitches has been reported to be between 16-and 91-fold [43, 44] .
The stimulating effect of kisspeptin on plasma LH concentration is ascribed to the kisspeptin-induced release of hypothalamic GnRH, since GnRH antagonists ablate this stimulation [4, 17, [21] [22] [23] . However, in comparison with GnRH antagonists, kisspeptin antagonists only partially inhibit LH, suggesting that GnRH secretion is only partially dependent on kisspeptin input [45] . It is, therefore, not surprising that GnRH induces even higher plasma LH concentrations in the bitch than does canine KP-10 [33, 35, 43, 44] . Similar results were observed by Hashizume et al. [16] in GnRH and KP-10 stimulation tests in female goats. The plasma LH response to GnRH was about 3 times higher and the FSH response 1.5 times higher than the response to the same dose of KP-10. In contrast, in pre-and post-pubertal male goats there was no difference in the plasma profiles of LH and testosterone after the administration of GnRH or KP-10 [46] . FSH concentration also rose rapidly after canine KP-10 administration. The 3-fold increase over basal FSH was similar to that after intravenous GnRH administration in anoestrous bitches [43, 44] . Plasma FSH concentrations remained above basal levels for a longer period than plasma LH concentrations. This is not surprising, as the half-life of FSH is longer than that of LH [47] .
Canine KP-10 administration resulted in a 2-to 3-fold increase in plasma oestradiol, which is similar to the effect of GnRH stimulation in anoestrous bitches [44, 45] . We observed maximum oestradiol concentrations at 60-90 min after canine KP-10 administration, which are similar to reported responses to GnRH in anoestrous bitches [32, 35, 43, 44] . This is not surprising, as kisspeptin indirectly stimulates gonadal steroids via hypothalamic GnRH release [1, 2, 4] .
In anoestrous bitches, we found FSH and oestradiol responses to canine KP-10 to be similar to the responses to GnRH, but the response of LH was much higher after GnRH. LH and FSH are both secreted by pituitary gonadotrophs, which are stimulated by GnRH. However, differential regulation of LH and FSH secretion has been demonstrated in this species, indicating the presence of additional regulatory mechanisms. For example, plasma LH concentrations before and after the preovulatory LH surge were similar, while FSH concentrations were lower before than after the concomitant FSH surge [31, 48] . Furthermore, FSH secretion is controlled by oestradiol and inhibin, while LH is not influenced by inhibin [49] .
In this study, we performed canine KP-10 stimulation tests in anoestrous bitches, beginning in early anoestrus (about 100 days after ovulation). The response to exogenous KP-10 may be influenced by the phase of the oestrous cycle, the pubertal stage and the sex steroid environment [14, 39, 42, 46] . The sensitivity of the canine pituitary to GnRH increases during the progression of anoestrus [35] and it is probable that the response to KP-10 may differ during the different phases of the cycle, since gonadal hormones exert positive or negative feedback on GnRH production and secretion. In this respect, it is interesting that GnRH neurons do not express sex steroid receptors [4, 17, 23, 50] . With the discovery of the kiss1/kiss1r system and the finding that kisspeptin-producing neurons express androgen and oestradiol receptors, and that GnRH neurons express kiss1r, it is likely that kisspeptin neurons form, also in the dog, the missing link in the communication between sex steroids and the GnRH neurons [4, 17, [21] [22] [23] 50] . It has been demonstrated that negative and positive feedback of the HPG axis is mediated by a down-or upregulation, respectively, of kiss1 mRNA in the hypothalamus. Furthermore, kiss1 mRNA expression in the hypothalamus is dependent on reproductive status and cycle stage [51, 52] . It is, therefore, not surprising that the gonadotrophin response to exogenous KP may differ throughout the different cycle stages, as has been shown in women [53] . However, data about gonadotrophin response to exogenous KP in the dog in different cycle phases are missing.
In the high-dosage group, there were no significant differences in the maximal plasma gonadotrophin and oestradiol responses, or in the AUCs, between different dosages of canine KP-10 (1-30 μg/kg). This suggests that maximum receptor occupancy and hormone responses had already been achieved at the dose of 1 μg/kg. Therefore, we also studied the effect of lower dosages of canine KP-10 on the plasma LH concentration. In contrast to the dose of 0.1 μg/kg, dosages of 0.2 μg/kg of canine KP-10 or higher led to a significant LH response. There were no significant differences in AUCs between the different dosages that led to a significant LH response, although there was a dose-related maximum LH response tendency. Furthermore, plasma LH concentrations returned to basal levels already at 30 min after intravenous administration of 0.2 and 0.3 μg/kg of canine KP-10, whereas after 0.5 and 1 μg/kg basal levels were reached at 40 min after canine KP-10 administration, which are similar to the results in the high-dosage group. This suggests that full receptor binding and activation is reached with a dose as low as 0.5 μg/kg of canine KP-10 in anoestrous bitches. The dosage causing the maximum LH response after an intravenous KP-10 bolus varied from 0.13 μg/kg in ovariectomized cows to 34.5 μg/kg in male monkeys [54, 55] . A dose-response study in humans demonstrated a maximum LH response at 1 μg/kg and showed a clear doserelated LH response with lower doses [38] . It can be concluded that the dog is rather sensitive to exogenous KP-10.
Conclusions
In this study we have demonstrated that both kiss1 and kiss1r are present in the canine genome and that intravenously administered KP-10 rapidly and robustly stimulates the secretion of LH, FSH and oestradiol in anoestrous bitches. These results suggest that kiss1/kiss1r sig-
